Sunshine Biopharma Stock Forecast

Sell candidate since Jun 09, 2026 Loss -4.39%

The Sunshine Biopharma, Inc. stock price gained 1.87% on the last trading day (Friday, 26th Jun 2026), rising from $2.14 to $2.18. During the last trading day the stock fluctuated 6.34% from a day low at $2.05 to a day high of $2.18. The price has fallen in 5 of the last 10 days and is down by -8.02% for this period. Volume fell on the last day by -601 thousand shares and in total, 63 thousand shares were bought and sold for approximately $136.35 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.25, a level that may pose a second chance to hit a runner. According to fan-theory $4.83 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBFM Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 23, 2026, and so far it has risen 6.86%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sunshine Biopharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.91. On a fall, the stock will find some support from the short-term average at $2.10. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

Sunshine Biopharma, Inc. finds support from accumulated volume at $2.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 6.34%. For the last week the stock has had daily average volatility of 6.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SBFM) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Sunshine Biopharma, Inc. to open at $2.14, and during the day (based on 14 day Average True Range), to move between $1.89 and $2.47, which gives a possible trading interval of +/-$0.573 (+/-30.28%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 30.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.14 (1.83%) than the resistance at $2.54 (16.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.178 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $2.14 ( 1.99%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk